SMi Partners with Expert Advisory Board to Launch Inaugural conference on Allergies
Allergies | 9th & 10th July, London UK
SMi Group Ltd is proud to release the conference agenda for their inaugural conference on Allergies
This conference brings together speakers from academia, industry and from the clinic to explore promising future therapies in allergy and in non- allergic eosinophilic inflammation
LONDON, LONDON, UNITED KINGDOM, March 6, 2014 /EINPresswire.com/ -- SMi Group have worked in partnership with an expert advisory board which includes KOLs from Imperial College London, Swecure AB and GSK, to put together the launch inaugural conference on Allergies.— Dr Glenis Scadding
The programme will examine key areas such as novel approaches in the treatment of allergy, therapeutic advances, allergic pathophysiology, a current update on food allergies, the future of allergen-specific immunotherapy and challenges, allergy prevention, diagnosis and drug development.
“This conference brings together speakers from academia, industry and from the clinic to explore promising future therapies in allergy and in non- allergic eosinophilic inflammation.” Dr Glenis Scadding, Honorary Consultant Allergist & Rhinologist, Royal National Throat, Nose and Ear Hospital
Key speakers will include:
• Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GSK
• Professor Alf Lindberg, Chief Scientific Director, Swecure AB
• Dr Rainer Henning, CEO, Biomay AG
• Dr Donna Finch, Principal Scientist, MedImmune
• Dr Glenis Scadding, Honorary Consultant Allergist & Rhinologist, Royal National Throat, Nose and Ear Hospital
• Calman Prussin, Principal Investigator, National Institute of Allergy and Infectious Diseases (NIAID)
• Professor Rudolf Valenta, Professor for Allergology, Medical University of Vienna
The PDF brochure featuring the full speaker line up and programme is now available to download at www.allergies-event.com
Allergies 2014 will aim to provide attendees with:
• Key case study driven presentation from GSK on new therapeutic tools for allergies
• A Clinicians' perspective – advances in allergy diagnostics featuring Royal Free Hospital and Imperial College London
• Insights from Allergy specialists – Dr Scadding and Dr Church, who will present on new research and findings
• Exclusive case study on the success of peanut allergy trials
• Guidance on development novel therapeutics and updates on allergy treatment breakthroughs
• Analysis of current and novel approaches of allergen-specific immunotherapy
For those who are interested there is currently a £300 discount available this month. Further details can be found here.
Allergies 2014
9th & 10th July 2014
Holiday Inn Hotel, Regents Park, London UK
www.allergies-event.com
Teri Arri
SMi Group Ltd
+44 (0)20 7827 6162
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
